Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Neuroendocrine-like differentiation of non-small cell lung carcinoma cells: regulation by cAMP and the interaction of mac25/IGFBP-rP1 and 25.1

Oncogene volume 25, pages 1943–1954 (2006)Cite this article

Abstract

The need to develop more effective therapies for lung cancer has led to investigations in understanding the molecular mechanisms of the differentiation process, in particular neuroendocrine (NE) differentiation. Recent studies have demonstrated that NE differentiation in non-small cell lung carcinoma (NSCLC) is not uncommon. Those NSCLCs with NE differentiation are considered a form of in transition NE carcinoma and show a more aggressive clinical course compared with NSCLC without NE differentiation. 25.1, a novel protein interacting with mac25/insulin-like growth factor-binding protein-related protein 1 (mac25/IGFBP-rP1), induced NE-like differentiation when collectively overexpressed in M12 prostate cancer cells. We have examined mac25/IGFBP-rP1 and 25.1 as potential molecular regulators in vitro of the NE-differentiation process in lung cancer. In a panel of SCLC and NSCLC cell lines, mac25/IGFBP-rP1 and 25.1 were expressed at higher levels in SCLC. An increase and sustained activation of adenosine 3′,5′-cyclic monophosphate (cAMP) levels induced NE-like differentiation in NSCLC cell lines, and a concomitant increase in the expression of mac25/IGFBP-rP1 and 25.1 was observed during the cAMP-regulated differentiation of NCI-H157 cells, suggesting the involvement of these proteins. Furthermore, the collective overexpression of mac25/IGFBP-rP1 and 25.1 in NSCLC cells induced NE-like differentiation as early as 6 h postinfection. The present data suggest that mac25/IGFBP-rP1 and 25.1 may play a functional role in the NE differentiation of NSCLC cell lines and may provide a novel therapeutic target for treating lung cancers, in particular NSCLC with NE differentiation.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7

Similar content being viewed by others

Abbreviations

NE:

neuroendocrine

SCLC:

small-cell lung carcinoma

NSCLC:

non-small-cell lung carcinoma

mac25/IGFBP-rP1:

mac25/insulin-like growth factor-binding protein-related protein 1

References

  • Ahmed S, Yamamoto K, Sato Y, Ogawa T, Herrmann A, Higashi S et al. (2003). Biochem Biophys Res Commun 310: 612–618.

  • Akaogi K, Okabe Y, Funahashi K, Yoshitake Y, Nishikawa K, Yasumitsu H et al. (1994). Biochem Biophys Res Commun 198: 1046–1053.

  • Akaogi K, Sato J, Okabe Y, Sakamoto Y, Yasumitsu H, Miyazaki K . (1996). Cell Growth Differ 7: 1671–1677.

  • Berendsen HH, de Leij L, Poppema S, Postmus PE, Boes A, Sluiter HJ et al. (1989). J Clin Oncol 7: 1614–1620.

  • Burger AM, Zhang X, Li H, Ostrowski JL, Beatty B, Venanzoni M et al. (1998). Oncogene 16: 2459–2467.

  • Carnaghi C, Rimassa L, Garassino I, Santoro A . (2001). Ann Oncol 12 (Suppl 2): S119–S123.

  • Cersosimo RJ . (2002). Am J Health Syst Pharm 59: 611–642.

  • Chen T, Cho RW, Stork PJ, Weber MJ . (1999). Cancer Res 59: 213–218.

  • Cox ME, Deeble PD, Bissonette EA, Parsons SJ . (2000). J Biol Chem 275: 13812–13818.

  • Deeble PD, Murphy DJ, Parsons SJ, Cox ME . (2001). Mol Cell Biol 21: 8471–8482.

  • Dimri GP, Lee X, Basile G, Acosta M, Scott G, Roskelley C et al. (1995). Proc Natl Acad Sci USA 92: 9363–9367.

  • Gajra A, Tatum AH, Newman N, Gamble GP, Lichtenstein S, Rooney MT et al. (2002). Lung Cancer 36: 159–165.

  • Gazdar AF, Helman LJ, Israel MA, Russell EK, Linnoila RI, Mulshine JL et al. (1988). Cancer Res 48: 4078–4082.

  • Gosney JR, Gosney MA, Lye M, Butt SA . (1995). Thorax 50: 116–120.

  • Graziano SL, Tatum A, Herdon II JE, Box J, Memoli V, Green MR et al. (2001). Lung Cancer 33: 115–123.

  • Graziano SL, Tatum AH, Newman NB, Oler A, Kohman LJ, Veit LJ et al. (1994). Cancer Res 54: 2908–2913.

  • Haugk KL, Wilson HM, Swisshelm K, Quinn LS . (2000). Endocrinology 141: 100–110.

  • Heasley LE . (2001). Oncogene 20: 1563–1569.

  • Hwa V, Oh Y, Rosenfeld RG . (1999). Endocr Rev 20: 761–787.

  • Iyoda A, Hiroshima K, Toyozaki T, Haga Y, Baba M, Fujisawa T et al. (2001). Cancer 92: 1108–1112.

  • Jiang SX, Kameya T, Sato Y, Yanase N, Yoshimura H, Kodama T . (1996). Am J Pathol 148: 837–846.

  • Jiang SX, Kameya T, Shinada J, Yoshimura H . (1999). Mod Pathol 12: 362–369.

  • Jull BA, Plummer III HK, Schuller HM . (2001). J Cancer Res Clin Oncol 127: 707–717.

  • Linnoila RI, Piantadosi S, Ruckdeschel JC . (1994). Chest 106 (6 Suppl): 367S–371S.

  • Lopez-Bermejo A, Buckway CK, Devi GR, Hwa V, Plymate SR, Oh Y et al. (2000). Endocrinology 141: 4072–4080.

  • Murphy M, Pykett MJ, Harnish P, Zang KD, George DL . (1993). Cell Growth Differ 4: 715–722.

  • Oh Y, Nagalla SR, Yamanaka Y, Kim HS, Wilson E, Rosenfeld RG . (1996). J Biol Chem 271: 30322–30325.

  • Pelosi G, Pasini F, Sonzogni A, Maffini F, Maisonneuve P, Iannucci A et al. (2003). Cancer 97: 2487–2497.

  • Reynolds SD, Hong KU, Giangreco A, Mango GW, Guron C, Morimoto Y et al. (2000). Am J Physiol Lung Cell Mol Physiol 278: L1256–L1263.

  • Schleusener JT, Tazelaar HD, Jung SH, Cha SS, Cera PJ, Myers JL et al. (1996). Cancer 77: 1284–1291.

  • Shaw GL, Gazdar AF, Phelps R, Linnoila RI, Ihde DC, Johnson BE et al. (1993). Cancer Res 53: 5181–5187.

  • Skov BG, Sorensen JB, Hirsch FR, Larsson LI, Hansen HH . (1991). Ann Oncol 2: 355–360.

  • Sprenger CC, Damon SE, Hwa V, Rosenfeld RG, Plymate SR . (1999). Cancer Res 59: 2370–2375.

  • Swisshelm K, Ryan K, Tsuchiya K, Sager R . (1995). Proc Natl Acad Sci USA 92: 4472–4476.

  • Tureckova J, Wilson EM, Cappalonga JL, Rotwein P . (2001). J Biol Chem 276: 39264–39270.

  • Vossler MR, Yao H, York RD, Pan MG, Rim CS, Stork PJ . (1997). Cell 89: 73–82.

  • Wallace WAH . (2002). Eur J Surg Oncol 28: 63–66.

  • Wilson EM, Oh Y, Hwa V, Rosenfeld RG . (2001). J Clin Endocrinol Metab 86: 4504–4511.

  • Wilson EM, Oh Y, Rosenfeld RG . (1997). J Clin Endocrinol Metab 82: 1301–1303.

  • Yamauchi T, Umeda F, Masakado M, Isaji M, Mizushima S, Nawata H . (1994). Biochem J 303 (Part 2): 591–598.

  • Yesner R . (2001). Exp Mol Path 70: 179–182.

Download references

Acknowledgements

This work was supported by an AACR-AstraZeneca-CRFA Research Fellowship in Translational Lung Cancer Research (to GEW) and an American Cancer Society Grant RPG-99-103-01-TBE (to YO).

Author information

Authors and Affiliations

  1. Department of Pediatrics, Oregon Health Sciences University, Portland, OR, USA

    G E Walker & Y Oh

  2. Oregon Cancer Center, Oregon Health Sciences University, Portland, OR, USA

    R J Antoniono

  3. Earle A Chiles Research Institute, Portland, OR, USA

    H J Ross

  4. Istituto Auxologico Italiano Piancavallo, Oggebbio, VB, Italy

    G E Walker

  5. Department of Pathology, Virginia Commonwealth University, Richmond, VA, USA

    T E Paisley & Y Oh

Authors
  1. G E Walker
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R J Antoniono
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. H J Ross
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. T E Paisley
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Y Oh
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Y Oh.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Walker, G., Antoniono, R., Ross, H. et al. Neuroendocrine-like differentiation of non-small cell lung carcinoma cells: regulation by cAMP and the interaction of mac25/IGFBP-rP1 and 25.1. Oncogene 25, 1943–1954 (2006). https://doi.org/10.1038/sj.onc.1209213

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1209213

Keywords

This article is cited by

Search

Advanced search

Quick links